ProQR Therapeutics N.V (PRQR) Enterprise Value: 2021-2025
Historic Enterprise Value for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to $229.3 million.
- ProQR Therapeutics N.V's Enterprise Value rose 49.64% to $229.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$97.1 million, marking a year-over-year decrease of 14.86%. This contributed to the annual value of $63.6 million for FY2024, which is 66.64% up from last year.
- According to the latest figures from Q3 2025, ProQR Therapeutics N.V's Enterprise Value is $229.3 million, which was up 353.11% from $50.6 million recorded in Q2 2025.
- ProQR Therapeutics N.V's 5-year Enterprise Value high stood at $432.3 million for Q3 2021, and its period low was -$146.2 million during Q1 2022.
- In the last 3 years, ProQR Therapeutics N.V's Enterprise Value had a median value of $38.9 million in 2023 and averaged $78.6 million.
- Its Enterprise Value has fluctuated over the past 5 years, first slumped by 171.17% in 2022, then skyrocketed by 734.07% in 2024.
- Quarterly analysis of 5 years shows ProQR Therapeutics N.V's Enterprise Value stood at $380.6 million in 2021, then slumped by 52.96% to $179.0 million in 2022, then tumbled by 78.30% to $38.9 million in 2023, then soared by 474.21% to $223.1 million in 2024, then spiked by 49.64% to $229.3 million in 2025.
- Its Enterprise Value stands at $229.3 million for Q3 2025, versus $50.6 million for Q2 2025 and -$17.2 million for Q1 2025.